ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,333.00
-2.00 (-0.15%)
Last Updated: 09:20:46
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.15% 1,333.00 1,333.00 1,334.00 1,337.50 1,333.00 1,335.00 350,393 09:20:46
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.22 55.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,335p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.34 billion. Gsk has a price to earnings ratio (PE ratio) of 11.22.

Gsk Share Discussion Threads

Showing 29651 to 29673 of 34075 messages
Chat Pages: Latest  1195  1194  1193  1192  1191  1190  1189  1188  1187  1186  1185  1184  Older
DateSubjectAuthorDiscuss
22/2/2022
11:06
That's $100bn, not £'s, not such a dream, but reflects what some experts believe the standalone entity to reach ...... ;0)
tradermichael
22/2/2022
10:45
100bn dreamland
spoole5
22/2/2022
09:36
OK, how about Beecham Healthcare?
tradermichael
22/2/2022
09:27
How about GSK Consumer Healthcare?
tradermichael
22/2/2022
09:19
I was thinking Microsoft Consumer Healthcare.
suresure
22/2/2022
09:17
spoole5 - GSK and Pfizer would have opened negotiations with Unilever's boss Alan Jope if the consumer goods giant was ready to improve its bid to more than 60 billion pounds, a source familiar with Pfizer's strategy said.

The source called the business a "legitimate standalone candidate", adding its market value could rise to almost $100 billion once the business was spun out and listed.

tradermichael
22/2/2022
09:14
Unilever consumer health?!
spoole5
22/2/2022
09:11
So if I got 1000 shares now when it splits will I get 500 shares in each of the new companies.
csalvage
22/2/2022
09:08
New name reveal today for CH business. Any guesses?
suresure
22/2/2022
09:02
Really will be fascinating to see the valuation the consumer side achieves post split. Bet it won't be anywhere near 50bn. That aside I'm sure there will be some handsome share option coming the way of executives!
spoole5
22/2/2022
07:44
What I dont get, is why do these moaners stay here month after month moaning? Why dont they simply move to a different company?
What on earth is going on?
Are the moaners nutters?

netcurtains
21/2/2022
22:30
She is a failure pure and simple, and they are trusting her to run the pharma side post split.
spoole5
21/2/2022
18:13
Not given yet. Should get more info on GSK's Consumer Healthcare Capital Markets Day,
next Monday 28th Feb

jonjoneil
21/2/2022
17:33
When is the split up
stevenrevell
21/2/2022
16:39
2017 when she took over as CEO she was talking about 'shareholder value' at the AGM. That was her priority she said in answer to a question from the floor. Five years later on the Ian King interview recently she was again talking about 'shareholder value'.
In all that time she has totally failed to produce any. I doubt it is even mentioned in her bonus contract. What a record!

jonjoneil
21/2/2022
14:39
spoole5

lipstick salesperson sounds better :-)

jonjoneil
21/2/2022
14:16
Helps when you aren't run by a lipstick saleswoman .
spoole5
21/2/2022
13:23
Looks like AZN has another block buster drug on its hands.

What a brilliant decision by the CEO to rebuff Pfizer, worth every penny
of his salary and more.

essentialinvestor
21/2/2022
13:20
Astra flies - Glaxo dives. What's new?
jonjoneil
20/2/2022
17:39
jonjoneil: Yes I've noticed that with shares, there is often a really steep fall before a prolonged rise begins. So interesting times
netcurtains
20/2/2022
15:10
All this positive news - not good for the share price
jonjoneil
20/2/2022
14:17
Also good article in today’s Mail on Sunday about the fact that the new “game-changing’ jab Shingrix will soon be available on the NHS.
Lots of very positive comments about the vaccine and its growth prospects. The only reason it is not already available is down to supply constraints that have now been addressed.
It is predicted that it will rapidly sweep aside the use of the significantly inferior Zostavax (Merck).

spyder
19/2/2022
10:52
Large article in today's Times on the proposed split, they sound very confident, capital markets day on the 28th to reveal more.
krowelet
Chat Pages: Latest  1195  1194  1193  1192  1191  1190  1189  1188  1187  1186  1185  1184  Older

Your Recent History

Delayed Upgrade Clock